Citigroup’s Meihua International Medical Technologies MHUA Stock Holding History

Citigroup’s Portfolio MHUA Stock Details MHUA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	–	–	6301
2025 Q3	–	Hold	0	–	–	–	6229
2023 Q1	–	Sell	-2	Closed	-$1.76K	–	5723
2022 Q4	$1.76K	Buy	+2	New	+$1.68K	﹤0.01%	5278

Citigroup's MHUA Position: Q4 2025 in Review

Citigroup held its Meihua International Medical Technologies (MHUA) position steady in Q4 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6301.

Citigroup first reported a position in MHUA in Q4 2022 and has held it in 1 quarter since. The position peaked at $1.76K in Q4 2022. 0 funds tracked by Wall St. Rank hold MHUA as of Q4 2025.

Citigroup held 0 shares of Meihua International Medical Technologies worth $0 as of Q4 2025.
Citigroup left its Meihua International Medical Technologies share count unchanged in Q4 2025.
Meihua International Medical Technologies made up ﹤0.01% of Citigroup's portfolio in Q4 2025, its #6301 holding.
Citigroup first reported a position in Meihua International Medical Technologies in Q4 2022 and has held it in 1 quarter since.
Citigroup's Meihua International Medical Technologies position peaked at $1.76K in Q4 2022.
0 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.